Georgetown University at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Georgetown University takes part in 2 sessions at CTAD 2026 in Boston. Its program spans the LiBBY trial of THC and CBD for agitation in advanced dementia and caregiver burden in hospice-eligible dementia.

Organization	CTAD 2026 Attendance
Georgetown University Washington, DC
	Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Burden Profiles by Caregiver Sex Among Hospice-Eligible Persons Living with Dementia: A Secondary Analysis of the LiBBY Phase II Trial (P155) Real-world data and access Talk Thu Nov 19 8:30am–9:10am Part of Lessons from The Life’s end Benefits of cannaBidiol and tetrahydrocannabinol (LiBBY) Study: Efficacy, Implementation, and Future Therapeutic Development in Advanced Dementia Effects of THC/CBD on NPI-Q Agitated Symptoms in Advanced Dementia: Results from the Double-Blind, Placebo-Controlled LiBBY Study Neuropsychiatric symptoms

Organization

CTAD 2026 Attendance

Georgetown University

Washington, DC

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Burden Profiles by Caregiver Sex Among Hospice-Eligible Persons Living with Dementia: A Secondary Analysis of the LiBBY Phase II Trial (P155)

Real-world data and access

Talk

Thu Nov 19
8:30am–9:10am

Part of Lessons from The Life’s end Benefits of cannaBidiol and tetrahydrocannabinol (LiBBY) Study: Efficacy, Implementation, and Future Therapeutic Development in Advanced Dementia

Effects of THC/CBD on NPI-Q Agitated Symptoms in Advanced Dementia: Results from the Double-Blind, Placebo-Controlled LiBBY Study

Neuropsychiatric symptoms

Instantly find 20 buyers from Georgetown University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction